TY - JOUR
T1 - Dual market structures and the likelihood of repeated ties - evidence from pharmaceutical biotechnology
AU - Roijakkers, A.H.W.M.
AU - Hagedoorn, J.
AU - Kranenburg, van, H.
PY - 2005
Y1 - 2005
N2 - This paper analyses the role of repeated ties in the high-tech pharmaceutical biotechnology industry, a sector that is characterized by a strong dual market structure. Our most important finding is that previous ties in pairs of large pharmaceutical companies and small biotechnology firms have a negative effect on their subsequent partnering. An explanation for this result is found in the context of understanding the specifics of large-small coalitions in a high-tech dual market structure. Unlike what is known about repeated ties in many other industries, this high-tech dual market structure indicates that R&D partnerships between a small number of very large companies and a large group of dependent, small firms are not characterized by mutual dependence, similarity, or equality.
AB - This paper analyses the role of repeated ties in the high-tech pharmaceutical biotechnology industry, a sector that is characterized by a strong dual market structure. Our most important finding is that previous ties in pairs of large pharmaceutical companies and small biotechnology firms have a negative effect on their subsequent partnering. An explanation for this result is found in the context of understanding the specifics of large-small coalitions in a high-tech dual market structure. Unlike what is known about repeated ties in many other industries, this high-tech dual market structure indicates that R&D partnerships between a small number of very large companies and a large group of dependent, small firms are not characterized by mutual dependence, similarity, or equality.
U2 - 10.1016/j.respol.2005.01.004
DO - 10.1016/j.respol.2005.01.004
M3 - Article
SN - 0048-7333
VL - 34
SP - 235
EP - 245
JO - Research Policy
JF - Research Policy
IS - 2
ER -